• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然多酚化合物对α-突触核蛋白寡聚物的抑制和解聚作用。

Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds.

机构信息

Dept. of Physiology & Biochemistry, University of Malta, Msida MSD 2080, Malta.

出版信息

FEBS Lett. 2011 Apr 20;585(8):1113-20. doi: 10.1016/j.febslet.2011.03.046. Epub 2011 Mar 31.

DOI:10.1016/j.febslet.2011.03.046
PMID:21443877
Abstract

Aggregation of alpha-synuclein (αS) into oligomers is critically involved in the pathogenesis of Parkinson's disease (PD). Using confocal single-molecule fluorescence spectroscopy, we have studied the effects of 14 naturally-occurring polyphenolic compounds and black tea extract on αS oligomer formation. We found that a selected group of polyphenols exhibited potent dose-dependent inhibitory activity on αS aggregation. Moreover, they were also capable of robustly disaggregating pre-formed αS oligomers. Based upon structure-activity analysis, we propose that the key molecular scaffold most effective in inhibiting and destabilizing self-assembly by αS requires: (i) aromatic elements for binding to the αS monomer/oligomer and (ii) vicinal hydroxyl groups present on a single phenyl ring. These findings may guide the design of novel therapeutic drugs in PD.

摘要

α-突触核蛋白(αS)的聚集在帕金森病(PD)的发病机制中起着关键作用。使用共聚焦单分子荧光光谱法,我们研究了 14 种天然多酚化合物和红茶提取物对αS 寡聚体形成的影响。我们发现,一组选定的多酚对αS 聚集表现出强烈的剂量依赖性抑制活性。此外,它们还能够有效地解聚预先形成的αS 寡聚物。基于结构-活性分析,我们提出最有效地抑制和破坏αS 自组装的关键分子支架需要:(i)用于与αS 单体/寡聚物结合的芳族元素,和(ii)单苯环上存在的相邻羟基。这些发现可能为 PD 的新型治疗药物设计提供指导。

相似文献

1
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds.天然多酚化合物对α-突触核蛋白寡聚物的抑制和解聚作用。
FEBS Lett. 2011 Apr 20;585(8):1113-20. doi: 10.1016/j.febslet.2011.03.046. Epub 2011 Mar 31.
2
Generation of ferric iron links oxidative stress to α-synuclein oligomer formation.生成的三价铁离子将氧化应激与α-突触核蛋白寡聚物的形成联系起来。
J Parkinsons Dis. 2011;1(2):205-16. doi: 10.3233/JPD-2011-11040.
3
Familial Parkinson disease mutations influence α-synuclein assembly.家族性帕金森病突变影响α-突触核蛋白的组装。
Neurobiol Dis. 2011 Sep;43(3):715-24. doi: 10.1016/j.nbd.2011.05.025. Epub 2011 Jun 7.
4
Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.酚类化合物可防止α-突触核蛋白寡聚化并降低突触毒性。
J Neurochem. 2015 Sep;134(5):943-55. doi: 10.1111/jnc.13180. Epub 2015 Jun 17.
5
Tryptophan fluorescence reveals structural features of alpha-synuclein oligomers.色氨酸荧光揭示了α-突触核蛋白寡聚体的结构特征。
J Mol Biol. 2009 Dec 18;394(5):826-33. doi: 10.1016/j.jmb.2009.10.021. Epub 2009 Oct 23.
6
Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing.寡聚α-突触核蛋白的膜结合取决于双层膜的电荷和堆积情况。
FEBS Lett. 2008 Nov 12;582(27):3788-92. doi: 10.1016/j.febslet.2008.10.009. Epub 2008 Oct 16.
7
Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.抑制剂结合态α-突触核蛋白二聚体的特性:α-突触核蛋白 N 端区域在二聚化和抑制剂结合中的作用。
J Mol Biol. 2010 Jan 22;395(3):445-56. doi: 10.1016/j.jmb.2009.10.068. Epub 2009 Nov 3.
8
Creation of aggregation-defective α-synuclein variants by engineering the sequence connecting β-strand-forming domains.通过工程化连接 β-折叠形成结构域的序列来创建聚集缺陷型 α-突触核蛋白变体。
Chembiochem. 2011 Nov 25;12(17):2630-9. doi: 10.1002/cbic.201100430. Epub 2011 Oct 13.
9
Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy.重组α-突触核蛋白的Cu2+结合模式——来自电子顺磁共振波谱的见解
J Am Chem Soc. 2008 Jun 18;130(24):7766-73. doi: 10.1021/ja800708x. Epub 2008 May 22.
10
Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.芘标记的α-突触核蛋白淀粉样蛋白聚集早期阶段的多参数荧光检测
J Mol Biol. 2008 May 16;378(5):1064-73. doi: 10.1016/j.jmb.2008.03.034. Epub 2008 Mar 26.

引用本文的文献

1
Plant-Based Inhibitors of Protein Aggregation.基于植物的蛋白质聚集抑制剂。
Biomolecules. 2025 Mar 25;15(4):481. doi: 10.3390/biom15040481.
2
Therapeutic Role of Scutellarein in Neurological Disorders.黄芩素在神经系统疾病中的治疗作用
Curr Pharm Des. 2025;31(20):1583-1592. doi: 10.2174/0113816128336901241125092132.
3
The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease.天然产物在帕金森病治疗中抑制α-突触核蛋白异常聚集的潜力。
Front Pharmacol. 2024 Oct 23;15:1468850. doi: 10.3389/fphar.2024.1468850. eCollection 2024.
4
Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies.帕金森病中α-突触核蛋白与膜的相互作用:机制和治疗策略。
Neurobiol Dis. 2024 Oct 15;201:106646. doi: 10.1016/j.nbd.2024.106646. Epub 2024 Aug 22.
5
Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease.聚焦肠脑轴:多酚、微生物群及其对帕金森病中α-突触核蛋白的影响。
Nutrients. 2024 Jun 27;16(13):2041. doi: 10.3390/nu16132041.
6
The impact of hUC MSC-derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity.人脐带来源间充质干细胞衍生的外泌体-纳米脂质体杂化物对 α-突触核蛋白纤维化和神经毒性的影响。
Sci Adv. 2024 Apr 5;10(14):eadl3406. doi: 10.1126/sciadv.adl3406. Epub 2024 Apr 3.
7
Targeting gasdermin E in neurodegenerative diseases.针对神经退行性疾病中的 Gasdermin E。
Cell Rep Med. 2023 Jun 20;4(6):101075. doi: 10.1016/j.xcrm.2023.101075.
8
Small molecules in regulating protein phase separation.小分子在调控蛋白质相分离中的作用。
Acta Biochim Biophys Sin (Shanghai). 2023 Jun 12;55(7):1075-1083. doi: 10.3724/abbs.2023106.
9
Analysis of phenolic compounds in Parkinson's disease: a bibliometric assessment of the 100 most cited papers.帕金森病中酚类化合物的分析:对100篇被引频次最高论文的文献计量学评估
Front Aging Neurosci. 2023 May 2;15:1149143. doi: 10.3389/fnagi.2023.1149143. eCollection 2023.
10
Endophytic Fusarium species, a unique bioresource for disaggregator of misfolded alpha-synuclein.内生镰刀菌属物种,一种用于解聚错误折叠的α-突触核蛋白的独特生物资源。
Arch Microbiol. 2023 May 8;205(6):224. doi: 10.1007/s00203-023-03575-z.